Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 8—August 2005

Research

Spoligotyping and Mycobacterium tuberculosis

Andrea Gori*Comments to Author , Alessandra Bandera*, Giulia Marchetti*, Anna Degli Esposti*, Lidia Catozzi*, Gian Piero Nardi*, Lidia Gazzola*, Giulio Ferrario*, Jan D.A. van Embden†, Dick van Soolingen†, Mauro Moroni*, and Fabio Franzetti*
Author affiliations: *University of Milan, Milan, Italy; †National Institute of Public Health and Environmental Protection, Bilthoven, the Netherlands

Main Article

Table 1

Characteristics of 148 patients with acid-fast bacilli in biologic specimens*

Age, y
Median (range) 34 (3–88)
Mean 39.3
Sex, no. (%)
Male 105 (70.9)
Female 43 (29.1)
Type of patient, no. (%)
Infectious diseases 124 (83.8)
Pneumology 10 (6.8)
Internal medicine 10 (6.8)
Other 4 (2.7)
HIV status, no. (%)
Negative 52 (35.1)
Positive 96 (64.9)
CD4+ cell count/μL†
Median 47.5
Mean (range) 105 (1–589)
Previous tuberculosis, no. (%) 20 (13.5)
Previous MAC infection, no. (%)
10 (6.8)
No tuberculosis or MAC infection, no. (%) 118 (79.7)

*MAC, Mycobacterium avium complex.
†Data available for 90 of 96 HIV-infected patients.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO